Search Within

Population Sciences Research Program

  1. "Nursing"
  2. "Radiology, Department of"
Formats
  1. Meeting Abstract (26)
  2. Journal Article (22)
Groups
  1. Nursing (48)
  2. Radiology, Department of (48)
  3. Department of Medicine (42)
  4. Epidemiology and Biostatistics (38)
  5. Biostatistics Service (33)
  6. Survivorship Research (30)

More Groups

People
  1. Steven Horwitz (21)
  2. Andrew Zelenetz (19)
  3. Paul Hamlin (18)
  4. Ariela Noy (17)
  5. David Straus (17)
  6. Craig Moskowitz (16)

More People

Years
  1. 2022 (3)
  2. 2021 (4)
  3. 2020 (3)
  4. 2019 (5)
  5. 2018 (2)
  6. 2017 (5)

More Years

Publications
  1. Journal of Clinical Oncology (16)
  2. Blood (11)
  3. Clinical Cancer Research (3)
  4. European Journal of Cancer (2)
  5. Hematological Oncology (2)
  6. American Journal of Hematology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (16)
  2. American Society of Hematology (11)
  3. American Association for Cancer Research (6)
  4. Wiley Blackwell (3)
  5. Elsevier Inc. (2)
  6. Elsevier Science, Inc. (2)

More Publishers

Results (48)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A pilot study of brentuximab vedotin combined with AVD chemotherapy and radiotherapy in patients with newly diagnosed early stage, unfavorable risk Hodgkin lymphoma
    Meeting Abstract

    Kumar, A.; Casulo, C.; Advani, R. H.; Budde, L. E.; Barr, P. M.; Batlevi, C. L.; Caron, P.; Constine, L. S.; Dandapani, S.; Drill, E.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Quality of life improves after palliative placement of percutaneous tunneled drainage catheter for refractory ascites in prospective study of patients with end-stage cancer
    Journal Article

    Robson, P.; Gonen, M.; Ni, A.; Brody, L.; Brown, K. T.; Getrajdman, G.; Thom, B.; Kline, N.; Covey, A.
    Palliative and Supportive Care (2019)

    Fulltext@MSK | Save
  • Genomic correlates of disease progression and treatment response in prospectively characterized gliomas
    Journal Article

    Jonsson, P.; Lin, A. L.; Young, R. J.; DiStefano, N. M.; Hyman, D. M.; Li, B. T.; Berger, M. F.; Zehir, A.; Ladanyi, M.; Solit, D. B.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Prospective genotyping of hepatocellular carcinoma: Clinical implications of next-generation sequencing for matching patients to targeted and immune therapies
    Journal Article

    Harding, J. J.; Nandakumar, S.; Armenia, J.; Khalil, D. N.; Albano, M.; Ly, M.; Shia, J.; Hechtman, J. F.; Kundra, R.; El Dika, I.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Phase 1b trial of an ibrutinib-based combination therapy in recurrent/refractory CNS lymphoma
    Journal Article

    Grommes, C.; Tang, S. S.; Wolfe, J.; Kaley, T. J.; Daras, M.; Pentsova, E. I.; Piotrowski, A. F.; Stone, J.; Lin, A.; Nolan, C. P.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Robust antitumor responses result from local chemotherapy and CTLA-4 blockade
    Journal Article

    Ariyan, C. E.; Brady, M. S.; Siegelbaum, R. H.; Hu, J.; Bello, D. M.; Rand, J.; Fisher, C.; Lefkowitz, R. A.; Panageas, K. S.; Pulitzer, M.; more...
    Cancer Immunology Research (2018)

    Fulltext@MSK | Save
  • Phase II trial of veliparib in patients with previously treated BRCA-mutated pancreas ductal adenocarcinoma
    Journal Article

    Lowery, M. A.; Kelsen, D. P.; Capanu, M.; Smith, S. C.; Lee, J. W.; Stadler, Z. K.; Moore, M. J.; Kindler, H. L.; Golan, T.; Segal, A.; more...
    European Journal of Cancer (2018)

    Fulltext@MSK | Save
  • Phase I dose escalation of ibrutinib and buparlisib in relapsed/refractory diffuse large B-cell lymphoma (DLBCL), mantle cell lymphoma (MCL), and follicular lymphoma (FL)
    Meeting Abstract

    Batlevi, C. L.; Hamlin, P. A.; Matasar, M. J.; Horwitz, S. M.; Gerecitano, J. F.; Moskowitz, C. H.; Straus, D. J.; Zelenetz, A. D.; Drullinsky, P.; Copeland, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase Ib/IIa trial of the combination of romidepsin, lenalidomide and carfilzomib in patients with relapsed/refractory lymphoma shows complete responses in relapsed and refractory B-and T-cell lymphomas
    Meeting Abstract

    Mehta-Shah, N.; Moskowitz, A. J.; Lunning, M. A.; Lynch, P.; Scheuerman, M.; Minnal, V.; Galasso, N.; Kumar, A.; Gerecitano, J.; Zelenetz, A. D.; more...
    Blood (2017)

    Fulltext@MSK | Save
  • Prognostic significance of baseline metabolic tumor volume in relapsed and refractory Hodgkin lymphoma
    Journal Article

    Moskowitz, A. J.; Schòˆder, H.; Gavane, S.; Thoren, K. L.; Fleisher, M.; Yahalom, J.; McCall, S. J.; Cadzin, B. R.; Fox, S. Y.; Gerecitano, J.; more...
    Blood (2017)

    Fulltext@MSK | Save